BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2687293)

  • 1. Expression of the fgr protooncogene product as a function of myelomonocytic cell maturation.
    Notario V; Gutkind JS; Imaizumi M; Katamine S; Robbins KC
    J Cell Biol; 1989 Dec; 109(6 Pt 1):3129-36. PubMed ID: 2687293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. fgr proto-oncogene is expressed during terminal granulocytic differentiation of human promyelocytic HL60 cells.
    Miyazaki Y; Katamine S; Kohno T; Moriuchi R; Miyamoto T; Tomonaga M
    Exp Hematol; 1993 Feb; 21(2):366-71. PubMed ID: 8425574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proto-oncogene c-fgr is expressed in normal mantle zone B lymphocytes and is developmentally regulated during myelomonocytic differentiation in vivo.
    Link DC; Zutter M
    Blood; 1995 Jan; 85(2):472-9. PubMed ID: 7812001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The c-fgr proto-oncogene: expression in Epstein-Barr-virus-infected B lymphocytes and in cells of the myelomonocytic and granulocytic lineages.
    Patel M; Faulkner L; Katz DR; Brickell PM
    Pathobiology; 1991; 59(4):289-92. PubMed ID: 1652975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocation of the FGR protein-tyrosine kinase as a consequence of neutrophil activation.
    Gutkind JS; Robbins KC
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8783-7. PubMed ID: 2682659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression and regulation of the c-src and c-fgr protooncogenes in myelomonocytic cells.
    Willman CL; Stewart CC; Griffith JK; Stewart SJ; Tomasi TB
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4480-4. PubMed ID: 2440024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages.
    Willman CL; Stewart CC; Longacre TL; Head DR; Habbersett R; Ziegler SF; Perlmutter RM
    Blood; 1991 Feb; 77(4):726-34. PubMed ID: 1825181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse biologic properties imparted by the c-fgr proto-oncogene.
    Sartor O; Moriuchi R; Sameshima JH; Severino M; Gutkind JS; Robbins KC
    J Biol Chem; 1992 Feb; 267(5):3460-5. PubMed ID: 1737799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel c-fgr exon utilized in Epstein-Barr virus-infected B lymphocytes but not in normal monocytes.
    Gutkind JS; Link DC; Katamine S; Lacal P; Miki T; Ley TJ; Robbins KC
    Mol Cell Biol; 1991 Mar; 11(3):1500-7. PubMed ID: 1847500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cloning and sequencing of the murine c-fgr gene.
    King FJ; Cole MD
    Oncogene; 1990 Mar; 5(3):337-44. PubMed ID: 2179817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
    Sharp NA; Luscombe MJ; Clemens MJ
    Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and chromosomal localization of the human fgr protooncogene, a distinct member of the tyrosine kinase gene family.
    Tronick SR; Popescu NC; Cheah MS; Swan DC; Amsbaugh SC; Lengel CR; DiPaolo JA; Robbins KC
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6595-9. PubMed ID: 2995972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation.
    Ferrari S; Manfredini R; Tagliafico E; Grande A; Barbieri D; Balestri R; Pizzanelli M; Zucchini P; Citro G; Zupi G
    Leukemia; 1994 Apr; 8 Suppl 1():S91-4. PubMed ID: 8152313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning of the murine c-fgr proto-oncogene cDNA and induction of c-fgr expression by proliferation and activation factors in normal bone marrow-derived monocytic cells.
    Yi TL; Willman CL
    Oncogene; 1989 Sep; 4(9):1081-7. PubMed ID: 2674853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific expression of human c-fgr in natural immunity effector cells.
    Inoue K; Yamamoto T; Toyoshima K
    Mol Cell Biol; 1990 Apr; 10(4):1789-92. PubMed ID: 2181286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary structure of the human fgr proto-oncogene product p55c-fgr.
    Katamine S; Notario V; Rao CD; Miki T; Cheah MS; Tronick SR; Robbins KC
    Mol Cell Biol; 1988 Jan; 8(1):259-66. PubMed ID: 3275868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of lineage-restricted protein tyrosine kinase genes in human natural killer cells.
    Biondi A; Paganin C; Rossi V; Benvestito S; Perlmutter RM; Mantovani A; Allavena P
    Eur J Immunol; 1991 Mar; 21(3):843-6. PubMed ID: 1826268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of c-fgr messenger RNA levels in U937 cells treated with different modulating agents.
    Faulkner L; Patel M; Brickell PM; Katz DR
    Immunology; 1992 May; 76(1):65-71. PubMed ID: 1628903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of src family genes during monocytic differentiation of HL-60 cells.
    Katagiri K; Katagiri T; Koyama Y; Morikawa M; Yamamoto T; Yoshida T
    J Immunol; 1991 Jan; 146(2):701-7. PubMed ID: 1987282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of the murine C-FGR genomic locus: exons IB-XII.
    Podhipleux N; Willman CL
    Oncogene; 1995 Aug; 11(4):781-4. PubMed ID: 7651742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.